Replies to post #3592 on Halozyme Therapeutics Inc (HALO)

[DFRAI]

Pfizer, Roche
It would be nice that once the new programs are known, they should be reflected on the HALO pipeline for investors to see it first hand.

[maumar]

I guess that's what shorts are counting on. Royalties won't ramp up significantly for a long time and there hasn't been enough progress on Halo's proprietary products. Roche is supposed to have up to 8 potential targets. Do we know if they are working on anything else?

I'm hoping for $4M in royalties in the third quarter. If we get $5M or more, I think the stock will take off even without other significant news.

[maumar]

Is Baxter using Halo technology for this?

http://www.businesswire.com/news/home/20141030005144/en/Baxter’s-Investigational-20-Subcutaneous-Immunoglobulin-Treatment-Meets#.VFMBbxY9Wp0

[onfish2000]

Rivipansel is in phase 1 trial. In addition, it appears Pfizer has elected to select 4 of the 6 therapeutic targets thus far, according to the Halo website. Hopefully we can get some color in the upcoming earnings call.